BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: WAS protein family member 3 (WASF3); NCK associated protein 1 (NCKAP1); cytoplasmic FMR1 interacting protein 1 (CYFIP1)

August 25, 2016 7:00 AM UTC

Patient sample, cell culture and mouse studies suggest that inhibiting the WASF3-NCKAP1-CYFIP1 complex could help treat metastatic breast cancer. In breast cancer patients, high tumor levels of NCKAP1...